Related Experiment Video
Updated: Jun 28, 2026

04:01
A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice
Published on: June 14, 2024
Animal models in myositis.
Yasuhiro Katsumata1, Dana P Ascherman
1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan. katsumata@ior.twmu.ac.jp
Current Opinion in Rheumatology
|October 24, 2008
Summary
Recent animal models advance understanding of idiopathic inflammatory myopathies. These models offer new insights into disease mechanisms and pave the way for developing effective therapies for polymyositis and inclusion body myositis.
Area of Science:
- Immunology
- Neurology
- Rheumatology
Background:
- Idiopathic inflammatory myopathies (IIMs) have complex and chronic disease mechanisms.
- Human studies are limited by patient population heterogeneity.
- Animal models are crucial for understanding IIM immunopathogenesis and testing therapies.
Purpose of the Study:
- To review recent animal models of myositis.
- To focus on models relevant to idiopathic inflammatory myopathy.
- To highlight advancements in understanding disease mechanisms and therapeutic strategies.
Main Methods:
- Review of recently published literature on myositis animal models.
- Focus on models applicable to polymyositis, inclusion body myositis, and dermatomyositis.
- Analysis of how these models elucidate pathogenic mechanisms.
Main Results:
- Significant progress in developing animal models for polymyositis and inclusion body myositis.
- Limited development in animal models for dermatomyositis.
- Novel models and refined existing models have clarified pathogenic mechanisms.
Conclusions:
- Emerging animal models provide new insights into idiopathic inflammatory myopathy pathophysiology.
- These models are foundational for developing novel and effective therapies.
- Future research using these models holds promise for treating intractable myositis cases.
